Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenues:    
License and other revenues $ 3,500
Expenses:    
Royalties 1,605
Research and development 34,360 31,091
General and administrative 29,851 19,004
Gain on operating lease right-of-use assets (1,065)
Total expenses 64,211 50,635
Loss from operations (64,211) (47,135)
Interest income 4,246 2,117
Interest expense (4,208) (418)
Change in fair value of warrant and derivative liabilities (755) (11,695)
Other income 1,194 2,943
Net loss $ (63,734) $ (54,188)
Basic loss per common share $ (1.55) $ (2.53)
Dilutive loss per common share $ (1.55) $ (2.53)
Weighted average number of common shares outstanding - basic 41,048,206 21,380,476
Weighted average number of common shares outstanding - diluted 41,048,206 21,380,476
Other comprehensive income (loss):    
Change in unrealized gains related to available-for-sale debt securities $ 74 $ 34
Foreign currency translation adjustments 29
Comprehensive loss $ (63,660) $ (54,125)